AGL 40.00 No Change ▼ 0.00 (0%)
AIRLINK 129.00 Decreased By ▼ -0.53 (-0.41%)
BOP 6.76 Increased By ▲ 0.08 (1.2%)
CNERGY 4.50 Decreased By ▼ -0.13 (-2.81%)
DCL 8.70 Decreased By ▼ -0.24 (-2.68%)
DFML 41.00 Decreased By ▼ -0.69 (-1.66%)
DGKC 81.30 Decreased By ▼ -2.47 (-2.95%)
FCCL 32.68 Decreased By ▼ -0.09 (-0.27%)
FFBL 74.25 Decreased By ▼ -1.22 (-1.62%)
FFL 11.75 Increased By ▲ 0.28 (2.44%)
HUBC 110.03 Decreased By ▼ -0.52 (-0.47%)
HUMNL 13.80 Decreased By ▼ -0.76 (-5.22%)
KEL 5.29 Decreased By ▼ -0.10 (-1.86%)
KOSM 7.63 Decreased By ▼ -0.77 (-9.17%)
MLCF 38.35 Decreased By ▼ -1.44 (-3.62%)
NBP 63.70 Increased By ▲ 3.41 (5.66%)
OGDC 194.88 Decreased By ▼ -4.78 (-2.39%)
PAEL 25.75 Decreased By ▼ -0.90 (-3.38%)
PIBTL 7.37 Decreased By ▼ -0.29 (-3.79%)
PPL 155.74 Decreased By ▼ -2.18 (-1.38%)
PRL 25.70 Decreased By ▼ -1.03 (-3.85%)
PTC 17.56 Decreased By ▼ -0.90 (-4.88%)
SEARL 78.71 Decreased By ▼ -3.73 (-4.52%)
TELE 7.88 Decreased By ▼ -0.43 (-5.17%)
TOMCL 33.61 Decreased By ▼ -0.90 (-2.61%)
TPLP 8.41 Decreased By ▼ -0.65 (-7.17%)
TREET 16.26 Decreased By ▼ -1.21 (-6.93%)
TRG 58.60 Decreased By ▼ -2.72 (-4.44%)
UNITY 27.51 Increased By ▲ 0.08 (0.29%)
WTL 1.41 Increased By ▲ 0.03 (2.17%)
BR100 10,450 Increased By 43.4 (0.42%)
BR30 31,209 Decreased By -504.2 (-1.59%)
KSE100 97,798 Increased By 469.8 (0.48%)
KSE30 30,481 Increased By 288.3 (0.95%)
Editorials

Scientists restore deafness in mice through gene-therapy

The evolving technology of gene therapy has led to many breakthroughs in the field of science. New research has sho
Published February 26, 2019 Updated February 27, 2019

The evolving technology of gene therapy has led to many breakthroughs in the field of science. New research has shown that gene therapy can now also cure inborn deafness.

According to a new research, gene therapy can now be used to cure and restore congenital deafness, as the results were positive in deaf mice that developed the ability to hear almost as well as healthy mice.

The mice suffered from DFNB9 deafness, a hearing disorder which accounts for between 2% and 8% of gene-related cases of human deafness. In this particular type of deafness, a protein named ‘otoferlin’ is unable to perform is task of submitting sound information gather by the fine hairs in the inner ear, explained Futurism.

In a first, scientists attempt to halt blindness through gene therapy

As described in the study published in the journal PNAS, after altering the deaf mice’s genomes with specially-crafted viruses by only a single intracochlear injection, the animals were able to hear almost as clearly as mice born with working otoferlin since their DNA segments were recombined, reported the team.

Even after altering the same specific gene in mice as what causes the DFNB9 deafness in humans, it still too early to claim that gene-editing technology can treat people as good as it did with the animals.

Copyright Business Recorder, 2019

Comments

Comments are closed.